Bamias, A. Merseburger, A. Loriot, Y. James, N. Choy, E. and Gauna, D. Castellano Lopez-Rios, F. Calabro, F. Kramer, M. W. de Velasco, G. Zakopoulou, R. Tzannis, K. and Sternberg, C. N., Prognostic factors related to post-platinum atezolizumab for relapsed
metastatic urothelial cancer (mUC) from the SAUL study, Annals of Oncology, (31), S581, 2020, Elsevier, 0923-7534, 1569-8041